Ebronucimab
- Generic Name
- Ebronucimab
- Brand Names
- 伊喜宁
Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/10/15 | Phase 1 | Not yet recruiting | |||
2022/03/02 | Phase 3 | Completed | |||
2022/02/24 | Phase 3 | Completed | |||
2022/02/24 | Phase 3 | Completed | |||
2020/04/24 | Phase 2 | Completed | |||
2019/11/22 | Phase 2 | Completed | |||
2019/11/19 | Phase 1 | Completed | |||
2019/05/01 | Phase 2 | Completed |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
国药准字S20240042 | 注射剂 | 伊喜宁 | 预充式自动注射笔：150 mg（1.5 mL）/支 | Biologics | Approved | 2024/09/26 | Domestic | ||
国药准字S20240041 | 注射剂 | 伊喜宁 | 预灌封注射器：150 mg（1.5 mL）/支 | Biologics | Approved | 2024/09/26 | Domestic |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug
© Copyright 2025. All Rights Reserved by MedPath